Results 141 to 150 of about 104,177 (305)

Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real‐Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy

open access: yesInternational Journal of Dermatology, Volume 64, Issue 11, Page 2038-2044, November 2025.
ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola   +12 more
wiley   +1 more source

Pharmacokinetic Monitoring of JAK Inhibitor and Tacrolimus for Safe and Effective Management of Graft‐Versus‐Host Disease After Pediatric Liver Transplantation

open access: yesPediatric Transplantation, Volume 29, Issue 7, November 2025.
ABSTRACT Background and Aim Though liver transplantation (LT) is effective for pediatric patients with end‐stage liver disease, it is associated with complications such as graft‐versus‐host disease (GVHD). In part due to its rarity and lack of standardized therapy, post‐LT GVHD is associated with a high mortality rate.
Keisuke Sawada   +5 more
wiley   +1 more source

Amphotericin B in the treatment of candida meningitis in three neonates

open access: yesThe Turkish Journal of Pediatrics, 1995
Candidiasis is an opportunistic infection and may result in significant morbidity and mortality in neonates. Cerebral candidiasis is rare and usually associated with systemic candidiasis.
M Aydin   +4 more
doaj  

Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi

open access: yesAdvanced Science, Volume 12, Issue 37, October 6, 2025.
The growing burden of drug‐resistant fungal infections, driven by pathogens such as Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus, underscores the urgent need for novel antifungal therapies. This review explores antimicrobial peptides as promising agents with membrane‐disruptive activity, immunomodulatory properties, and delivery ...
Cesar Augusto Roque‐Borda   +12 more
wiley   +1 more source

Changes in the epidemiological landscape of invasive candidiasis

open access: yesJournal of Antimicrobial Chemotherapy, 2018
F. Lamoth   +3 more
semanticscholar   +1 more source

A Rare Case of Blastomycosis in a Psoriasis Patient Treated With Ustekinumab (Stelara)

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Psoriasis is a chronic inflammatory skin condition mediated by T‐helper 1 (Th1) and T‐helper 17 (Th17) cytokines, including interleukin (IL)‐12, IL‐23, IL‐17, and tumor necrosis factor alpha (TNF‐α). Ustekinumab, a human monoclonal antibody against the p40 subunit of IL‐12/23, has revolutionized treatment of moderate to severe psoriasis but ...
Fatima Ghaffar   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy